In the last few years, the incorporation of gene expression profiling (GEP) in the examination of MM patients with EMD has designated alterations in centrosome genes like CKS1B, YWHAZ, CTBS, NADK [20,24], and NEAT1 [25]. This evidence concerns the gene CTBS and Miyoshi myopathy.